Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 289

Results For "AP"

8945 News Found

Danone India sets record with 20,911 healthcare pledges to fight anemia
Healthcare | April 05, 2026

Danone India sets record with 20,911 healthcare pledges to fight anemia

The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign


Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail
News | April 05, 2026

Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail

The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores


Senores makes bold US push with new federal-focused JV
News | April 05, 2026

Senores makes bold US push with new federal-focused JV

Company leadership is framing the move as transformational.


Innovent Biologics’ OLN324 shows breakthrough results in vision disease study
Biopharma | April 05, 2026

Innovent Biologics’ OLN324 shows breakthrough results in vision disease study

The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred


Jan Vishwas Bill 2026 decriminalises minor health sector offences, eases compliance burden
Public Health | April 04, 2026

Jan Vishwas Bill 2026 decriminalises minor health sector offences, eases compliance burden

Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws


Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib
Drug Approval | April 04, 2026

Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib

ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA


Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma
Biotech | April 04, 2026

Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma

The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy


Abbott launches nationwide Vitamin C awareness campaign
Healthcare | April 04, 2026

Abbott launches nationwide Vitamin C awareness campaign

The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day


Kauvery Hospital sets new benchmark in high-risk cardiac care
Hospitals | April 04, 2026

Kauvery Hospital sets new benchmark in high-risk cardiac care

71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day


Q2 2026 drug catalysts put Replimune, Arvinas and Boehringer in sharp focus: GlobalData
Biopharma | April 03, 2026

Q2 2026 drug catalysts put Replimune, Arvinas and Boehringer in sharp focus: GlobalData

Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning